| Factor | Source | Drives |
|---|---|---|
| EPO | Kidney (hypoxia) | RBCs |
| TPO | Liver | Megakaryocytes → platelets |
| G-CSF | Macrophages, stroma | Neutrophils (filgrastim) |
| GM-CSF · M-CSF | T cells, macrophages | Granulocytes + monocytes · monocytes |
| IL-3 · IL-5 · IL-7 | T cells · Th2 · stroma | Early progenitors · eosinophils · lymphoid |
| Stem cell factor | Stroma | Stem cells, mast cells (KIT) |
JAK2 sits under the EPO, TPO and G-CSF receptors → JAK2 V617F lets cells grow without the hormone (PV, ET, myelofibrosis).
Differential order: "Never Let Monkeys Eat Bananas." Cellularity: 100 − age.
Normal adult marrow does contain some lymphocytes (~10–15%). What's abnormal is a lymphoid aggregate (especially paratrabecular) or sheets of one cell type.
| Family | Defining idea | Examples |
|---|---|---|
| Myeloid neoplasms | ||
| Acute myeloid leukemia | ≥20% myeloblasts; maturation block | AML t(8;21), APL t(15;17) |
| Myelodysplastic | Ineffective, dysplastic; cytopenias; blasts <20% | MDS del(5q); monosomy 5, 7 |
| Myeloproliferative | Effective overproduction; tyrosine kinase mutations | CML (BCR-ABL), PV, ET, PMF (JAK2) |
| Lymphoid neoplasms | ||
| Precursor | Lymphoblasts, TdT+ | B-ALL, T-ALL / lymphoblastic lymphoma |
| Mature B | Mimic a B-cell stage | CLL/SLL, follicular, mantle, MZL, DLBCL, Burkitt, hairy cell, LPL, myeloma |
| Mature T/NK | Post-thymic T cells | Mycosis fungoides/Sézary, ATLL, ALCL |
| Hodgkin | Few RS cells, reactive background | Classic (4) and NLPHL |
WHO = morphology + immunophenotype + genetics + clinical: ancillary studies are required.
(1) Lineage: myeloid (MPO, CD13, CD33, CD117) vs lymphoid (B: CD19/20; T: CD3). (2) Maturity: blasts (TdT, CD34) vs mature cells.
Chromosome losses in MDS: monosomy 5 and 7.
| Term | Meaning |
|---|---|
| Lymphadenopathy | Enlarged node(s); nonspecific |
| Hyperplasia | ↑ cells; in nodes by pattern: follicular (B zone), paracortical (T zone; EBV, phenytoin), sinus histiocytosis |
| Auer rod | Pink-red needle in myeloid blast cytoplasm (fused primary granules); AML, especially APL |
| Russell body | Cytoplasmic PAS+ Ig; myeloma |
| Dutcher body | Intranuclear Ig; Waldenström |
| Reactive | Follicular lymphoma | |
|---|---|---|
| Follicles | Varied sizes, in cortex | Crowded, back-to-back, uniform, beyond capsule |
| Germinal centers | Polarized, tingible-body macrophages, mitoses | Monotonous, no polarity |
| Mantle | Intact | Thin/absent |
| BCL2 in GC | Negative | Positive |
| Clonality | κ and λ | Light-chain restricted |
| Leukemia | Lymphoma | |
|---|---|---|
| Origin | Bone marrow | Lymph nodes, lymphoid tissue, solid organs |
| Blood | Spill-over common; often high WBC | Usually not |
| Lineage | Myeloid or lymphoid | Lymphoid only (HL vs NHL; B vs T) |
| Tempo | Acute (blasts) vs chronic | Indolent vs aggressive |
| Presents as | Marrow failure ± leukocytosis | Mass / lymphadenopathy |
The name follows the location: same cells in marrow/blood = leukemia, in a node = lymphoma. Tumor cells in the blood → it's behaving as a leukemia.
CLL, hairy cell and mycosis fungoides are leukemias; follicular, mantle and marginal zone are lymphomas, not leukemias.
Anemia (fatigue) · Bleeding (platelets) · Contagion (neutrophils): "packed marrow, empty blood."
Tender, rapidly enlarging node with fever → reactive. Painless, rubbery, progressive (>2 cm, supraclavicular, >4–6 weeks) → lymphoma → excisional biopsy.
| Acute leukemia | CML | CLL | Hairy cell | |
|---|---|---|---|---|
| Onset | Abrupt | Insidious | Insidious | Indolent, progressive |
| Blood | High WBC (blasts) with neutropenia | Very high WBC, all stages | High WBC, mature lymphocytes | Pancytopenia, hairy cells |
| Symptoms | Bleeding, unusual (fungal) infections | Organomegaly | Diffuse nodes | Splenomegaly |
| Course | Urgent | → AML or fibrosis | Not curable | BRAF; long remissions |
Hairy cell: circulating hairy cells, splenomegaly, pancytopenia.
| Test | Answers | Classic use |
|---|---|---|
| Smear | What cells? | Blasts, Auer rods, smudges, hairy cells, left shift, basophilia, rouleaux, dysplasia |
| Chemistry | Turnover, organs | LDH, uric acid (tumor lysis), Ca, creatinine, protein/albumin, β2-microglobulin |
| Marrow aspirate | Cell morphology | Differential, flow, cytogenetics |
| Marrow core | Architecture | Cellularity, fibrosis, infiltrates (paratrabecular aggregate) |
| Flow cytometry | Lineage, maturity, clonality | CLL (CD5/23), ALL (TdT), AML (CD13/33), hairy (CD103) |
| IHC | Markers in tissue | BCL2 follicles, cyclin D1, CD15/30, CD138 |
| Cytochemistry | Myeloid vs lymphoid | MPO (AML), esterase (monocytic), TRAP (hairy), LAP (low in CML) |
| Cytogenetics / FISH | Translocations | t(9;22), t(15;17), t(14;18), t(11;14), t(8;14), del(17p) |
| Molecular | Mutations, MRD | BCR-ABL, JAK2, BRAF, MYD88, FLT3, NPM1 |
| Protein studies | Monoclonal Ig | Myeloma, Waldenström, MGUS |
Excisional node biopsy beats fine-needle aspiration: it shows the pattern (follicular vs diffuse, Hodgkin background) and gives enough tissue for ancillary tests.
| Lymphoma | Pattern | CD5 | CD10 | CD23 | Cyclin D1 | Genetics |
|---|---|---|---|---|---|---|
| CLL/SLL | Diffuse, proliferation centers | + | − | + | − | Trisomy 12 (30%) |
| Lymphoplasmacytic | Diffuse | − | − | − | − | MYD88; IgM |
| Mantle cell | Diffuse, vaguely nodular | + | − | − | + | t(11;14) |
| Follicular | Follicular ± diffuse | − | + | −/+ | − | t(14;18) BCL2 |
| Marginal zone | Diffuse, interfollicular | − | − | +/− | − | Trisomy 18, t(11;18) |
CD5+? → CLL (CD23+) or mantle (cyclin D1+). CD10+? → follicular. Neither? → marginal zone or lymphoplasmacytic (IgM spike = LPL).
| Disease | Patient | Outcome |
|---|---|---|
| ALL | Child 2–10 | Kids ~90% cured; adults worse |
| AML | Adult ~65 | Remission 60–70%; transplant; APL excellent (ATRA) |
| CML | Middle-aged | Near-normal with TKIs; untreated → blast crisis |
| CLL · follicular · mantle | Older | Indolent, incurable (4–10 y · 7–10 y · 3–5 y); → DLBCL |
| DLBCL · Burkitt | Adults · kids | Aggressive but curable |
| Hairy cell | Older men | Long remissions (cladribine) |
| Hodgkin | Young + >50 | 75–90% curable early; late effects |
| Myeloma | ~70 | Incurable |
Method: (1) blood, marrow, node or organ? (2) cellularity / fat? (3) one cell type or a mix? (4) small vs large (compare with RBCs)? (5) special features: Auer rods, hairs, smudges, fibrosis, owl eyes, hof? (6) pattern: follicular, diffuse, paratrabecular?
AML smear = blasts + Auer rods (lumpy blasts with small purple rods). Bundles of Auer rods → APL.
Lymphoid aggregates hugging bony trabeculae → follicular lymphoma. Fleshy enlarged nodes → NHL. Large cells in sheets: lymphoma vs carcinoma → IHC (CD45/CD20 vs keratin).
Splenic masses are far more likely hematopoietic than metastatic carcinoma; >4 splenic nodules is an adverse factor in Hodgkin.
Punched-out skull → myeloma; IL-6 (from plasma + stromal cells) drives plasma cell proliferation. Guaranteed question.
1A 3-year-old has 4 days of fever, gum bleeding and petechiae; WBC is 68,500/µL. What will the marrow show?
2An adult's smear shows large blasts with prominent nucleoli and pink needle-shaped cytoplasmic inclusions. These inclusions are:
3What is the expected marrow cellularity of a healthy 60-year-old?
4Which growth factor is made by the liver and drives platelet production?
5A marrow core shows a lymphoid aggregate lining a bony trabecula beside normal myeloid cells. Most likely diagnosis?
6A 58-year-old has a painless 3-cm supraclavicular node for 2 months. Best biopsy?
7A 66-year-old's node shows small B cells that are CD5+, CD23−, CD10−. Which confirms the diagnosis?
8A 62-year-old with pneumonia has WBC 30,000/µL of mature neutrophils, toxic granulation, Döhle bodies and high LAP. Diagnosis?
9Which pair is the same disease presenting as a leukemia or a lymphoma?
10Which cytokine drives plasma cell proliferation in myeloma?
11Pancytopenia argues against which diagnosis?
12A tissue mass shows sheets of large cells. Which IHC pair best separates lymphoma from carcinoma?
| Item | Lecture | Step 1 / standard references |
|---|---|---|
| Auer rods | Abnormal secondary granules | Fused primary (azurophilic) granules |
| AML blast cutoff | ≥20% | t(8;21), inv(16), t(15;17) = AML at any blast count |
| Marginal zone genetics | Trisomy 18, t(11;18) | Trisomy 3 (± 18); t(11;18) in MALT |
| MZL markers | CD23 "+/−", CD43 "−" | Key on CD5− and CD10− (CD43+ in a subset) |
| DLBCL cure | ~50% | ~60–70% with R-CHOP |
| Lymphocytes in marrow | "Adults should not have lymphoid cells in the marrow" | Normal marrow has ~10–15% lymphocytes; aggregates/sheets are abnormal |